Is Ravulizumab safe while breastfeeding?
Here is what NIH LactMed, the U.S. National Library of Medicine's authority on medicines and breastfeeding, reports about Ravulizumab. This is a summary of that source — not our own verdict.
Effects on the breastfed infant
A single-center, retrospective review of 19 women who received ravulizumab during pregnancy and postpartum revealed 16 mothers who breastfed during ravulizumab therapy. After a median follow-up of 16.2 months (IQR 4.4 to 40.1 months), no developmental abnormalities or severe infectious complications were observed in the children.[ 2 ]
Effects on milk supply
Relevant published information was not found as of the revision date.
Levels in milk
Maternal Levels. Relevant published information was not found as of the revision date. Infant Levels. Relevant published information was not found as of the revision date.
Alternatives LactMed lists
Source: NIH LactMed (National Library of Medicine).
Educational summary of an authoritative source — not medical advice. Never start, stop, or change a medicine while breastfeeding without confirming with your doctor.